The use of selective serotonin reuptake inhibitors for depression and psychosis complicating dementia

International Journal of Geriatric Psychiatry

Volumn 12, Issue 5, 1997, Pages 519-525

  Burke, William J ^a,b   Dewan, Vijay ^a   Wengel, Steven P ^a   Roccaforte, William H ^a   Nadolny, Grace C ^a   Folks, David G ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Dementia; Depression; Selective serotonin reuptake inhibitors

Indexed keywords

PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DEMENTIA; DEPRESSION; DIARRHEA; DRUG TOLERANCE; FEMALE; HUMAN; MALE; PSYCHOSIS;

1-NAPHTHYLAMINE; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DEMENTIA; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; PAROXETINE; PSYCHOTIC DISORDERS; RETROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS; SERTRALINE;

EID: 0030965338     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1166(199705)12:5<519::AID-GPS534>3.0.CO;2-Q     Document Type: Article

References (25)

1. Bergman, I., Bråne, G., Gottfries, C. G., Jostle, K.-G., Karlsson, I. et al., (1983) Alaproclate: A pharmacokinetic and biochemical study in patients with dementia of Alzheimer type. Psychopharmacology 80, 279-283.
2. Burke, W. J., Folks, D. G., Roccaforte, W. H. and Wengel, S. P. (1994) Serotonin reuptake inhibitors for the treatment of coexisting depression and psychosis in dementia of the Alzheimer type. Am. J. Geriatr. Psychiat. 2(4), 352-354.
3. Colenda, C. C. (1988) Buspirone in treatment of agitated demented patients. Lancet 2, 1169.
4. Cross, A. J. (1990) Serotonin in Alzheimer-type dementia and other dementing illnesses. Ann. NY Acad. Sci. 600, 405-415.
5. Dehlin, O., Hedenrud, B., Jansson, P. and Nörglas, J. (1985) A double-blind comparison of alaproclate and placebo in the treatment of patients with senile dementia. Acta Psychiatr. Scand. 71, 190-196.
6. Francis, P. T., Cross, A. J. and Bowen, D. M. (1994) Neurotransmitters and neuropeptides. In Alzheimer Disease (R. D. Terry, R. Katzman and K. L. Bick, Eds) Raven Press, New York.
7. Geldmacher, D. S., Waldman, A. J., Doty, L. and Heilmanm, K. M. (1994) Fluoxetine in dementia of the Alzheimer's type: prominent adverse effects and failure to improve cognition. J. Clin. Psychiat. 55, 161.
8. Gottfries, G. G. (1994) Therapy options in Alzheimer's disease. Brit. J. Clin. Pract. 48(6), 327-330.
9. Gottfries, G. G., Karlsson, I., and Nyth, A. L. (1992) Treatment of depression in elderly patients with and without dementia disorders. Int. Clin. Psychopharmacol. 6(Suppl. 5), 55-64.
10. Gottfries, G. G. and Nyth, A. L. (1991) Effect of citalopram, a selective 5-HT reuptake blocker, in emotionally disturbed patients with dementia. Ann. NY Acad. Sci. 640, 276-279.
11. Herrmann, N. and Eryavec, G. (1993) Buspirone in the management of agitation and aggression associated with dementia. Am. J. Geriatr. Psychiat. 1(3), 249-253.
12. Houlihan, D. J., Mulsant, B. H., Sweet, R. A., Rifai, A. H., Pasternak, R. et al. (1994) A naturalistic study of trazodone in the treatment of behavioral complications of dementia. Am. J. Geriatr. Psychiat. 2(1), 78-85.
13. Jørgenson, S., Bille, A., Andersen, J., Jensen, H. V., Olafsson, K. et al. (1993) Fluvoxamine treatment of dementia: Tryptophan levels. Biol. Psychiat. 34, 587-588.
14. Lawlor, B. A., Sunderland, T., Mellow, A. M., Hill, J. L., Molchan, S. E. et al. (1989) Hyperresponsivity to the serotonin agonist m-chlorophenylpiperazine in Alzheimer's disease. Arch. Gen. Psychiat. 46, 542-549.
15. Lebert, F., Pasquier, F. and Petit, H. (1994) Behavioral effects of trazodone in Alzheimer's disease. J. Clin. Psychiat. 55, 536-538.
16. McLoughlin, D. M., Lucey, J. V. and Dinan, T. G. (1994) Central serotonergic hyperresponsivity in late-onset Alzheimer's disease. Am. J. Psychiat. 151, 1701-1703.
17. Nyth, A. L. and Gottfries, C. G. (1990) The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders: A Nordic multicentre study. Brit. J. Psychiat. 157, 894-901.
18. Nyth, A. L., Gottfries, C. G., Lyby, K., Smedegaard-Anderson, L., Gylding-Sabroe, J. et al. (1992) A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia. Acta Psychiatr. Scand. 86, 138-145.
19. Olofsson, K., Jørgensen, S., Jensen, H. V., Bille, A., Arup, P. et al. (1992) Fluvoxamine in the treatment of demented elderly patients: A double-blind, placebo-controlled study. Acta Psychiatr. Scand. 85, 453-456.
20. Sakauye, K. M., Camp, C. J. and Ford, P. A. (1993) Effects of buspirone on agitation associated with dementia. Am. J. Geriatr. Psychiat. 1(1), 82-84.
21. Schneider, L.S. and Sobin, P. B. (1991) Non-neuroleptic medications in the management of agitation in Alzheimer's disease and other dementia: A selective review. Int. J. Geriatr. Psychiat. 6, 691-708.
22. Schneider, L. S. and Sobin, P. B. (1992) Non-neuroleptic treatment of behavioral symptoms and agitation in Alzheimer's disease and other dementia. Psychopharmaco. Bull. 28(1), 71-79.
23. Tiller, J. W. G., Dakis, J. A. and Shaw, J. M. (1988) Short term buspirone treatment in disinhibition with dementia. Lancet 2, 510.
24. Volicer, L., Rheaume, Y. and Cyr, D. (1994) Treatment of depression in advanced Alzheimer's disease using sertraline. J. Geriatr. Psychiat. Neurol. 7, 227-229.
25. Zubenko, G. S., Moossy, J., Martinez, A. J., Rao, G., Claasen, D. et al. (1991) Neuropathologic and neurochemical correlates of psychosis in primary dementia. Arch. Neurol. 48, 619-622.